China Opens New Registration Regs For Comment, Industry Urged To 'Weigh In'
Executive Summary
Following the passing of a new Pharmaceutical Administration Law, which will take effect on 1 December, China’s National Medical Products Administration has now released a second draft of its Drug Registration Regulations, and observers are urging stakeholders to actively submit comments on the highly important framework.